Download PDF
Planta Med 1998; 64(6): 500-503
DOI: 10.1055/s-2006-957501
Papers
Pharmacology
© Georg Thieme Verlag Stuttgart · New York

In vitro Antigenotoxic Activity of Novel Ginseng Saponin Metabolites Formed by Intestinal Bacteria

Byung-Hoon Lee1 , Sang-Jun Lee1 , 2 , Jang-Hyun Hui2 , Sooyong Lee3 , Jong-Hwan Sung4 , Jae-Doo Huh4 , Chang-Ku Moon5
  • 1College of Pharmacy, Wonkwang University, Iksan, Chonbuk, Korea
  • 2Department of Agricultural Chemistry, Kangwon National University, Chunchon, Kangwon-do, Korea
  • 3Institute of Environment and Life Sciences, Hallym University, Chunchon, Kangwon-do, Korea
  • 4Central Research Institute, IL HWA Co. Ltd., Guri, Kyonggi-do, Korea
  • 5College of Pharmacy, Seoul National University, Seoul, Korea
Further Information

Publication History

1997

1998

Publication Date:
01 February 2007 (online)

Also available at
  PDF Download  Permissions and Reprints

Abstract

Ginseng saponin metabolites produced by human intestinal bacteria were evaluated for antigenotoxic properties by testing their effects on benzo[a]pyrene (B[a]P)-induced mutagenicity and clastogenicity. They include 20-O-(β-D-glucopyranosyl)-20(S)-protopanaxadiol (IH-901), 20-O-[α-D-arabinopyranosyl(1→6)-β-D-glucopyranosyl]-20(S)-protopanaxadiol (IH-902) and 20-O-[α-D-arabinofuranosyl(1→6)-β-D-glucopyranosyl]-20(S)-protopanaxadiol (IH-903). IH-901, IH-902 and IH-903 inhibited the mutagenicity of B[a]P in a dose-dependent manner. In the chromosome aberration assay, IH-901 and IH-903 reduced the frequency of chromosome aberration induced by B[a]P. These results suggest that the ginseng saponin metabolites tested in the present study have potential as chemopreventive agents.

Key words

Panax ginseng - Araliaceae - ginseng saponin metabolites - antimutagenicity - anticlastogenicity - benzo[a]pyrene - chemoprevention